Two hundred eight patients with apical hypertrophic cardiomyopathy in China: Clinical feature, prognosis, and comparison of pure and mixed forms

Clinical Cardiology

Volumn 35, Issue 2, 2012, Pages 101-106

  Yan, Lirong ^a   Wang, Zhimin ^a   Xu, Zhimin ^a   Li, Yishi ^a   Tao, Yongkang ^a   Fan, Chaomei ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; APICAL HYPERTROPHIC CARDIOMYOPATHY; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; CHINA; CLINICAL FEATURE; COMORBIDITY; COMPARATIVE STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RECORD REVIEW; MONOTHERAPY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PHENOTYPE; PREDICTIVE VALUE; PROBABILITY; PROGNOSIS; Q WAVE; RETROSPECTIVE STUDY; T WAVE INVERSION; THORAX RADIOGRAPHY;

ANGIOGRAPHY; CARDIOMYOPATHY, HYPERTROPHIC; CHINA; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84857055222     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20995     Document Type: Article

References (32)

1. Elliott P, McKenna WJ., Hypertrophic cardiomyopathy. Lancet. 2004; 363: 1881-1891. (Pubitemid 38748646)
2. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J. 2003; 24: 1965-1991. (Pubitemid 37336422)
3. Sakamoto T, Tei C, Murayama M, et al. Giant T wave inversion as a manifestation of asymmetrical apical hypertrophy (AAH) of the left ventricle. Echocardiographic and ultrasono-cardiotomographic study. Jpn Heart J. 1976; 17: 611-629. (Pubitemid 8005798)
4. Yamaguchi H, Ishimura T, Nishiyama S, et al. Hypertrophic nonobstructive cardiomyopathy with giant negative T waves (apical hypertrophy): ventriculographic and echocardiographic features in 30 patients. Am J Cardiol. 1979; 44: 401-412.
5. Sakamoto T, Amano K, Hada Y, et al. Asymmetric apical hypertrophy: ten years experience. Postgrad Med J. 1986; 62: 567-570. (Pubitemid 16038700)
6. Sakamoto T, Suzuki J., Apical hypertrophic cardiomyopathy [in Japanese]. Nihon Rinsho. 2000; 58: 93-101.
7. Eriksson MJ, Sonnenberg B, Woo A, et al. Long-term outcome in patients with apical hypertrophic cardiomyopathy. J Am Coll Cardiol. 2002; 39: 638-645. (Pubitemid 34158160)
8. Partanen J, Kupari M, Heikkila J, et al. Left ventricular aneurysm associated with apical hypertrophic cardiomyopathy. Clin Cardiol. 1991; 14: 936-939.
9. Furushima H, Chinushi M, Iijima K, et al. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy. J Cardiovasc Electrophysiol. 2010; 21: 991-999.
10. Louie EK, Maron BJ., Apical hypertrophic cardiomyopathy: clinical and two-dimensional echocardiographic assessment. Ann Intern Med. 1987; 106: 663-670. (Pubitemid 17067981)
11. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000; 102: 858-864.
12. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ ASE 2003 guideline update for the clinical application of echocardiography - summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Coll Cardiol. 2003; 42: 954-970. (Pubitemid 37069224)
13. Koga Y, Itaya K, Toshima H., Prognosis in hypertrophic cardiomyopathy. Am Heart J. 1984; 108: 351-359. (Pubitemid 14061378)
14. Kitaoka H, Doi Y, Casey SA, et al. Comparison of prevalence of apical hypertrophic cardiomyopathy in Japan and the United States. Am J Cardiol. 2003; 92: 1183-1186. (Pubitemid 37377828)
15. Maron BJ., Hypertrophic cardiomyopathy: a systematic review. JAMA. 2002; 287: 1308-1320. (Pubitemid 34250486)
16. Lee CH, Liu PY, Lin LJ, et al. Clinical features and outcome of patients with apical hypertrophic cardiomyopathy in Taiwan. Cardiology. 2006; 106: 29-35.
17. Koga Y, Katoh A, Matsuyama K, et al. Disappearance of giant negative T waves in patients with the Japanese form of apical hypertrophy. J Am Coll Cardiol. 1995; 26: 1672-1678.
18. Pillarisetti J, Gupta K., Giant inverted T waves in the emergency department: case report and review of differential diagnoses. J Electrocardiol. 2010; 43: 40-42.
19. Park SY, Park TH, Kim JH, et al. Relationship between giant negative T-wave and severity of apical hypertrophy in patients with apical hypertrophic cardiomyopathy. Echocardiography. 2010; 27: 770-776.
20. Maron BJ., Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy. Circulation. 2010; 121: 445-456.
21. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003; 42: 1687-1713. (Pubitemid 37383745)
22. Schaff HV, Brown ML, Dearani JA, et al. Apical myectomy: a new surgical technique for management of severely symptomatic patients with apical hypertrophic cardiomyopathy. J Thorac Cardiovasc Surg. 2010; 139: 634-640.
23. Acarturk E, Bozkurt A, Donmez Y., Apical hypertrophic cardiomyopathy: diagnosis with contrast-enhanced echocardiography - a case report. Angiology. 2003; 54: 373-376. (Pubitemid 36578472)
24. Moukarbel GV, Alam SE, Abchee AB., Contrast-enhanced echocardiography for the diagnosis of apical hypertrophic cardiomyopathy. Echocardiography. 2005; 22: 831-833. (Pubitemid 44933447)
25. Moon JC, Fisher NG, McKenna WJ, et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart. 2004; 90: 645-649. (Pubitemid 38668538)
26. Ates M, Kwong RY, Lipton MJ, et al. Apical hypertrophic cardiomyopathy: diagnosed by cardiac magnetic resonance imaging. Tex Heart Inst J. 2006; 33: 408-409. (Pubitemid 44683449)
27. Kubo T, Kitaoka H, Okawa M, et al. Clinical profiles of hypertrophic cardiomyopathy with apical phenotype - comparison of pure-apical form and distal-dominant form. Circ J. 2009; 73: 2330-2336.
28. Choi EY, Rim SJ, Ha JW, et al. Phenotypic spectrum and clinical characteristics of apical hypertrophic cardiomyopathy: multicenter echo-Doppler study. Cardiology. 2008; 110: 53-61.
29. Arad M, Penas-Lado M, Monserrat L, et al. Gene mutations in apical hypertrophic cardiomyopathy. Circulation. 2005; 112: 2805-2811. (Pubitemid 41641675)
30. Gruner C, Care M, Siminovitch K, et al. Sarcomere protein gene mutations in patients with apical hypertrophic cardiomyopathy. Circ Cardiovasc Genet. 2011; 4: 288-295.
31. Monserrat L, Hermida-Prieto M, Fernandez X, et al. Mutation in the alpha-cardiac actin gene associated with apical hypertrophic cardiomyopathy, left ventricular non-compaction, and septal defects. Eur Heart J. 2007; 28: 1953-1961. (Pubitemid 47579548)
32. Seidman CE, Seidman JG., Identifying sarcomere gene mutations in hypertrophic cardiomyopathy: a personal history. Circ Res. 2011; 108: 743-750.